
2019 DIA Editor’s Take – Axiom Real-Time Metrics
Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics
Andrew Schachter explains how sponsors can us technology to achieve trial objectives more quickly and easily even as clinical research becomes increasingly complex and as FDA regulations demand more accountability.
For more information please visit www.axiommetrics.com/.